Female Pattern Hair Loss: Understanding the Ludwig Scale

The Ludwig Classification

The Ludwig Scale, developed in 1977, classifies female pattern hair loss into three grades:

• Grade I (mild): Perceptible thinning on the crown with the part line beginning to widen. Often only noticeable to the patient. Hair density is reduced but scalp is minimally visible.
• Grade II (moderate): Pronounced thinning across the crown. The part line is clearly widened. Scalp is visible through the hair, especially under overhead lighting.
• Grade III (severe): Near-complete hair loss over the crown, leaving only a thin, diffuse covering. The frontal hairline is typically preserved (the "Christmas tree" pattern when viewed from above).

An alternative classification — the Sinclair Scale (grades 1-5) — provides more granular grading and is also widely used.

What Causes Female Pattern Hair Loss?

FPHL results from a combination of genetics, hormones, and aging:

• Genetics: Polygenetic inheritance from both parents. Family history is the strongest predictor.
• Androgens: While some women have elevated androgens (PCOS), many have normal hormone levels. Their follicles may be more sensitive to normal androgen levels.
• Aging: Hair follicles progressively miniaturize — producing finer, shorter, less pigmented hairs until they produce only vellus (peach fuzz) hair
• Menopause: Declining estrogen unmasks androgen effects, which is why many women notice accelerated thinning around menopause

Treatment Options

Minoxidil (first-line):

• The only FDA-approved topical treatment for FPHL
• 5% foam applied once daily is more effective than 2% solution
• Stimulates follicles and extends the growth phase
• About 40-60% of women see improvement; most see stabilization
• Results visible at 4-6 months; shedding in the first 2-4 weeks is normal and expected
• Must be used continuously — stopping leads to loss of gains within 3-6 months
• Oral minoxidil (0.25-2.5mg daily) is an emerging off-label option with potentially better adherence

Anti-androgen therapy:

• Spironolactone (100-200mg daily): Anti-androgen widely used off-label for FPHL. Blocks androgen receptors at the follicle. Takes 6-12 months for visible improvement. Must use contraception.
• Combined oral contraceptives: With anti-androgenic progestins (drospirenone, cyproterone acetate) to reduce free testosterone
• Finasteride (off-label, 1-5mg daily): Less studied in women than men. Some evidence for benefit in postmenopausal women. Absolutely contraindicated in pregnancy.

Adjunctive treatments:

• PRP (platelet-rich plasma): Growth factor injections showing modest benefit in clinical trials. 3-4 sessions initially.
• Low-level laser therapy: FDA-cleared devices showing modest improvement in hair counts.
• Iron supplementation: If ferritin is below 30 ng/mL (common in premenopausal women), correcting iron deficiency can improve hair growth independent of other treatments.

Frequently Asked Questions

Is female pattern hair loss reversible?

FPHL can be stabilized and partially reversed with treatment, but it's a chronic condition requiring ongoing therapy. Earlier treatment (Ludwig grade I-II) produces better results because miniaturized follicles respond better than fully dormant ones.

Should I get blood tests?

Yes. Your dermatologist should check: complete blood count, ferritin, vitamin D, thyroid function (TSH), and potentially testosterone and DHEA-S. These tests rule out treatable causes that can mimic or worsen FPHL.

Can hair transplant help women?

Hair transplant can be effective for select women with stable FPHL and adequate donor hair density. However, women are generally considered less ideal candidates than men because their thinning is often diffuse rather than localized, meaning donor areas may also be thin. A thorough evaluation by a hair restoration specialist is needed.